Related Products
|
||||||
About
EquiReason is an equity research and market-intelligence platform for self-directed investors, independent analysts and research teams. It combines SEC company filings, XBRL financial data, earnings-call transcripts and market information to help users examine financial performance, ownership activity, trends and company exposure. The platform traces market events through economic mechanisms to potentially affected companies and presents each company verdict with supporting and counter-evidence. Research views include financial statements, valuation context, insider and institutional activity, segment revenue data, company-specific measures and alerts, with evidence linked to its underlying source. EquiReason is available through the web and an iPhone app, with a free plan and paid research tiers. It provides research and decision support, not investment advice.
|
About
IMPLAN employs the most thorough economic data available and pairs it with the most advanced economic impact modeling application to deliver the information you’re seeking after just a few clicks. The combination of IMPLAN’s data and analytical application provides analysts with the most complete and comprehensive picture of any economic event and its effects. IMPLAN’s economic data is constantly being vetted by industry-leading economic research analysts. Experts consistently agree that it is the most accurate and reliable data available. Whether you’re a seasoned researcher or just getting into the economic modeling game, IMPLAN is designed to be simple to use while giving you the power to be as methodologically rigorous as you desire. Your personal, in-house customer success manager is standing by to help you get the most out of the data and the app no matter how complex your study might be.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Self-directed stock investors, independent analysts, finance writers and small research teams covering US equities
|
Audience
Data analysis tool for organizations wanting to gain insight of the influence that their decisions and operations have on their economies
|
|||||
Support
Phone Support
Not Supported
24/7 Live Support
Not Supported
Online
Not Supported
|
Support
Phone Support
Supported
24/7 Live Support
Not Supported
Online
Supported
|
|||||
API
Offers API
Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and VideosNo images available
|
Screenshots and Videos |
|||||
Pricing
$49/month
Free plan available. Analyst is $49/month; Research Pro is $89/month. Annual billing is ten months for twelve. Research Pro has a seven-day trial with no card required.
Free Version
Supported
Free Trial
Supported
|
Pricing
No information available.
Free Version
Not Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Not Supported
Webinars
Not Supported
Live Online
Not Supported
In Person
Not Supported
|
Training
Documentation
Supported
Webinars
Supported
Live Online
Supported
In Person
Not Supported
|
|||||
Company InformationEquiReason
Founded: 2026
Turkey
equireason.com
|
Company InformationIMPLAN
Founded: 1985
United States
www.implan.com/platform/
|
|||||
Alternatives |
Alternatives |
|||||
|
|
|
|||||
|
|
||||||
|
|
||||||
Categories |
Categories |
|||||
Integrations
No info available.
|
Integrations
No info available.
|
|||||
|
|
|